The effect of exon (19C>A) dihydroorotate dehydrogenase gene polymorphism on rheumatoid arthritis treatment with leflunomide

Author： Pawlik Andrzej   Herczynska Magdalena   Kurzawski Mateusz   Safranow Krzysztof   Dziedziejko Violetta   Drozdzik Marek  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.10, Iss.2, 2009-02, pp. : 303-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Leflunomide for the treatment of rheumatoid arthritis

By Miceli-Richard Corinne   Dougados Maxime  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomide

By Dziedziejko Violetta   Kurzawski Mateusz   Safranow Krzysztof   Chlubek Dariusz   Pawlik Andrzej  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 41-47

Future Medicine

Access to resources Recommend Favorite

The effect of 3435C>T MDR1 gene polymorphism on rheumatoid arthritis treatment with disease-modifying antirheumatic drugs

By Drozdzik Marek   Rudas Tomasz   Pawlik Andrzej   Kurzawski Mateusz   Czerny Bogusław   Gornik Wanda   Herczynska Magdalena  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 11, 2006-11 ,pp. : 933-937

Springer Publishing Company

Access to resources Recommend Favorite

Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis

By Alldred A.   Emery P.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 125-137

Informa Healthcare

Access to resources Recommend Favorite

Leflunomide for the Treatment of Rheumatoid Arthritis in Clinical Practice: Incidence and Severity of Hepatotoxicity

By van Roon E.N.   Jansen T.L.T.A.  

Drug Safety, Vol. 27, Iss. 5, 2004-01 ,pp. : 345-352

Adis International

Access to resources Recommend Favorite